The next
generation
of nature.

Cannabigerol (CBG) is yet to match the mainstream appeal of CBD, but will soon play a significant role in everyday consumer life as it demonstrates a wide array of intriguing medicinal benefits. This bioactive ingredient activates both CB1 and CB2 cannabinoids receptors and has already received significant interest by discriminating formulators who appreciate that it exhibits anti-bacterial, anti-microbial, and anti-inflammatory properties. A summary of recent research with this cannabinoid has been involved with the following areas:

• Antimicrobial
• Antioxidant effects
• Digestion and intestines
• Inflammation
• Nausea
• Pain

Cannabidiol (CBD) is the posterchild of the cannabinoid industry and earns its reputation by binding to CB2 cannabinoid receptors within our bodies’ endocannabinoid system. This effects our peripheral nervous system to help regulate various physiological functions with muscles, immune cells, skin, and other organs. A summary of recent research with this cannabinoid has been involved with the following areas:

• Inflammation
• Recovery
• Pain
• Brain and central nervous system
• Cardiovascular system

Cannabigerivarin (CBGV) is theorized to boost the ability of the CB2 receptors within the endocannabinoid system and those found in our immune system, as well as impact how other cannabinoids molecules are activated and metabolized within the body, especially as it relates to pain and inflammation. A summary of recent research with this cannabinoid has been involved with the following areas:

• Inflammation
• Skin
• Pain
• Eyes

Tetrahydrocannabivarin (THCV) is similar to THC in chemical structure, exerts similar psychoactive effects on the body at higher level of intake, yet unlike THC actually mitigates this effect at lower levels of intake. These opposing impacts based upon concentration and dosage may be explained by it acting as both an agonist and an antagonist at CB1 receptors, with additional peripheral tissue effects related to neurogenesis and satiety. A summary of recent research with this cannabinoid has been involved with the following areas:

• Appetite Suppressant
• Brain
• Bone Growth
• Metabolism

Cannabidivarin (CBDV) like its parent compound CBD, is well positioned through active pharmaceutical ingredient research as a potentially powerful cannabinoid related to epileptic seizures. It acts at both CB1 and CB2 cannabinoid receptors and also effects how endogenous cannabinoids are synthesized within the endocannabinoid system. A summary of recent research with this cannabinoid has been involved with the following areas:

• Brain and peripheral nervous system
• Nausea
• Seizures
• Immunity